Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cleveland BioLabs' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha
Friday, November 9, 2012 - 11:09am
tags:
Cleveland BioLabs, earnings
Novo Aims for Tresiba U.S. Approval in First Half of 2013
Bloomberg
Friday, November 9, 2012 - 11:07am
tags:
Novo Nordisk, Tresiba, diabetes, degludec, insulin
FDA reviewing Merck's experimental insomnia drug
Boston.com, MA
Friday, November 9, 2012 - 10:03am
tags:
FDA, Merck, suvorexant, insomnia
Bristol-Myers, Chiromics form drug discovery strategic alliance
Yahoo/Fly the on Wall
Friday, November 9, 2012 - 9:56am
tags:
Chiromics, drug discovery, Bristol-Myers Squibb
Amarin Still Playing the Dating Game
Motley Fool
Friday, November 9, 2012 - 9:50am
tags:
Amarin, M&A, AstraZeneca
Does Amarin Need the FDA to Play NCE?
Motley Fool
Friday, November 9, 2012 - 8:53am
tags:
Amarin, Vascepa, FDA, NCE
Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
NY Times, NY
Thursday, November 8, 2012 - 10:22pm
tags:
drug pricing, Sanofi, Sloan Kettering, colon cancer, Zaltrap
Jazz Pharma Earnings Top Estimates As Xyrem Ramps
Investors.com
Thursday, November 8, 2012 - 10:19pm
tags:
Jazz Pharmaceuticals, earnings
Mylan To Wall Street: Forget Patent Cliff, We'll Grow
Investors.com
Thursday, November 8, 2012 - 9:54pm
tags:
Mylan, patents, generics, Teva, Watson Pharmaceuticals
FDA panel recommends approval of Novo degludec insulin
Reuters
Thursday, November 8, 2012 - 9:52pm
tags:
FDA, advisory panels, Novo Nordisk, degludec, insulin
Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.
NASDAQ.com
Thursday, November 8, 2012 - 12:08pm
tags:
Sun Pharma, DUSA pharmaceuticals, M&A, India
ImmunoGen Is Living Life in the Fast Lane
Motley Fool
Thursday, November 8, 2012 - 12:07pm
tags:
Immunogen, Roche, T-DM1, breast cancer
Amicus Therapeutics Poised For Rebound Into December Phase III Results
Seeking Alpha
Thursday, November 8, 2012 - 12:05pm
tags:
Amicus Therapeutics, GSK, Amigal
3 Stocks With High Alphas: Acadia, Hemispherx, And Vringo
Seeking Alpha
Thursday, November 8, 2012 - 12:04pm
tags:
Acadia, Hemispherx Biopharma
Think Of Pfizer As A Cigarette Company
Seeking Alpha
Thursday, November 8, 2012 - 12:03pm
tags:
Pfizer
POZEN Reports Third Quarter 2012 Financial Results and Positive PA32540 Clinical Updates
Yahoo
Thursday, November 8, 2012 - 11:13am
tags:
earnings, Pozen
What Orexigen Is Saying -- and Not Saying
Motley Fool
Thursday, November 8, 2012 - 11:00am
tags:
Orexigen, obesity, Contrave, Arena Pharmaceuticals, Vivus
Canada top court rules against Pfizer in Viagra case
Reuters
Thursday, November 8, 2012 - 10:59am
tags:
Canada, Pfizer, Viagra, patents, erectile dysfunction, Teva
Novartis says expects to have 14 new blockbusters by 2017
Reuters
Thursday, November 8, 2012 - 10:57am
tags:
Novartis, LCZ696, serelaxin
AstraZeneca, PTSD And A Buried Seroquel Study
Pharmalot
Thursday, November 8, 2012 - 10:54am
tags:
PTSD, AstraZeneca, Seroquel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.